Overview
Friedreich's ataxia is a neurodegenerative disorder characterized by progressive neurological deficits, often accompanied by cardiomyopathy, including hypertrophic cardiomyopathy and conduction abnormalities 67.Diagnosis
Clinical Features: Progressive gait and limb ataxia, dysarthria, areflexia, and motor weakness 3.
Electrocardiographic Changes: Frequent QRS complex abnormalities, right ventricular hypertrophy pattern on vectocardiogram 7.
Recommended Tests: Serial electrocardiograms (ECGs) and vectocardiograms to monitor cardiomyopathy progression 7.
Cardiac Evaluation: Echocardiography to assess for hypertrophic cardiomyopathy and coronary artery involvement 6.Management
First-Line Treatments:
- High-Dose Thiamine: Intramuscular therapy with 100 mg every 3-5 days to address potential thiamine deficiency 3.
- Electroconvulsive Therapy (ECT): For depression, considered safe and effective 5.
Adjunctive Treatments:
- Nicotinamide: High-dose oral supplementation (2-8 g daily) for potential epigenetic and neurological benefits; further studies needed for definitive efficacy 2.
- Left Ventricular Support Devices: In severe cases, devices like Impella 2.5 may be necessary for hemodynamic support 1.Special Populations
Pediatrics: Consideration of advanced hemodynamic support devices like Impella in severe cases 1.
Comorbidities: Management of depression with ECT when other treatments are challenging due to multiple medical conditions 5.Key Recommendations
Monitor Cardiac Function Regularly: Serial ECGs and echocardiograms to detect cardiomyopathy and arrhythmias early 7 (Evidence: Strong).
Consider High-Dose Thiamine Therapy: For patients with suspected thiamine deficiency, intramuscular thiamine may improve motor symptoms 3 (Evidence: Moderate).
Evaluate and Treat Depression: Use ECT as a viable treatment option for depression in patients with Friedreich's ataxia 5 (Evidence: Moderate).References
1 Sandoval Boburg R, Mustafi M, Magunia H, Kling S, Schlensak C, Popov AF. Left ventricular unloading with transaortic Impella 2.5 implantation in a pediatric patient supported by extracorporeal life support. Artificial organs 2021. link
2 Libri V, Yandim C, Athanasopoulos S, Loyse N, Natisvili T, Law PP et al.. Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study. Lancet (London, England) 2014. link60382-2)
3 Costantini A, Giorgi R, D'Agostino S, Pala MI. High-dose thiamine improves the symptoms of Friedreich's ataxia. BMJ case reports 2013. link
4 Blaney B, Hewlett N. Voicing status of word final plosives in Friedreich's Ataxia dysarthria. Clinical linguistics & phonetics 2007. link
5 Singh G, Binstadt BA, Black DF, Corr AP, Rummans TA. Electroconvulsive therapy and Friedreich's ataxia. The journal of ECT 2001. link
6 Sohi GS, Drake C, Flowers NC. Friedreich's ataxia associated with hypertrophic cardiomyopathy and coronary vasospasm. Clinical cardiology 1985. link
7 Malo S, Latour Y, Cote M, Geoffroy G, Lemieux B, Barbeau A. Electrocardiographic and vectocardiographic findings in Friedreich's ataxia. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1976. link